Skip to main content
. Author manuscript; available in PMC: 2013 Apr 21.
Published in final edited form as: Female Pelvic Med Reconstr Surg. 2012 Sep-Oct;18(5):274–280. doi: 10.1097/SPV.0b013e318263a210

Table 3.

Major postoperative complications after benign gynecologic procedures (N =19,439)

Complication Derivative Cohort N =9,572 Validation Cohort N = 9,867 P-value
Death 12 (0.13) 10 (0.10) .62
Cardiac arrest 8 (0.08) 5 (0.05) .38
Acute myocardial infarction 2 (0.02) 6 (0.06) .17
Postoperative coma > 24 hours 1 (0.01) 1 (0.01) .98
CVA with neurologic deficit 2 (0.02) 1 (0.01) .55
Acute renal failure 7 (0.07) 5 (0,05) .53
Progressive renal insufficiency 7 (0.07) 6 (0.06) .74
Deep wound surgical site infection 35 (0.37) 22 (0.22) .07
Organ space surgical site infection 62 (0.65) 57 (0.58) .53
Wound dehiscence 37 (0.39) 25 (0.25) .10
Pulmonary embolism 20 (0.21) 27 (0.27) .36
Deep vein thrombosis 10 (0.10) 12 (0.12) .83
Prolonged mechanical ventilation 20 (0.21) 15 (0.15) .35
Unplanned reintubation 25 (0.26) 17 (0.17) .18
Pneumonia 19 (0.20) 30 (0.30) .14
Sepsis 42 (0.44) 50 (0.51) .49
Septic Shock 21 (0.22) 10 (0.10) .04
Blood transfusion 22 (0.23) 12 (0.12) .07
Return to the Operating Room 150 (1.57) 156 (1.58) .94
Composite Major Morbidity 319 (3.33) 317 (3.21) .64

All values listed as n(%) unless otherwise specified

Blood transfusion includes the transfusion of packed red blood cells or whole blood cells within 72 hours of completion of surgery.

Return to the Operating Room includes the return to the surgical operating room for any reasons within 30 days of surgery.